Kalaris Therapeutics, Inc. (KLRS)
4.10
-0.05
(-1.20%)
USD |
NASDAQ |
Aug 24, 16:00
4.08
-0.02
(-0.49%)
Pre-Market: 20:00
Kalaris Therapeutics Total Return Level : 4.10 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 4.10 |
| August 21, 2026 | 4.15 |
| August 20, 2026 | 4.12 |
| August 19, 2026 | 4.17 |
| August 18, 2026 | 4.03 |
| August 17, 2026 | 3.96 |
| August 14, 2026 | 4.08 |
| August 13, 2026 | 3.88 |
| August 12, 2026 | 3.94 |
| August 11, 2026 | 3.97 |
| August 10, 2026 | 3.94 |
| August 07, 2026 | 4.07 |
| August 06, 2026 | 4.19 |
| August 05, 2026 | 4.19 |
| August 04, 2026 | 4.32 |
| August 03, 2026 | 4.05 |
| July 31, 2026 | 3.51 |
| July 30, 2026 | 3.48 |
| July 29, 2026 | 3.40 |
| July 28, 2026 | 3.34 |
| July 27, 2026 | 3.58 |
| July 24, 2026 | 3.73 |
| July 23, 2026 | 3.92 |
| July 22, 2026 | 4.07 |
| July 21, 2026 | 4.04 |
| Date | Value |
|---|---|
| July 20, 2026 | 4.00 |
| July 17, 2026 | 4.38 |
| July 16, 2026 | 4.61 |
| July 15, 2026 | 4.82 |
| July 14, 2026 | 4.55 |
| July 13, 2026 | 4.42 |
| July 10, 2026 | 4.44 |
| July 09, 2026 | 4.49 |
| July 08, 2026 | 4.71 |
| July 07, 2026 | 4.83 |
| July 06, 2026 | 4.65 |
| July 02, 2026 | 4.75 |
| July 01, 2026 | 4.53 |
| June 30, 2026 | 4.07 |
| June 29, 2026 | 4.215 |
| June 26, 2026 | 4.32 |
| June 25, 2026 | 4.30 |
| June 24, 2026 | 4.40 |
| June 23, 2026 | 4.47 |
| June 22, 2026 | 4.40 |
| June 18, 2026 | 4.72 |
| June 17, 2026 | 4.55 |
| June 16, 2026 | 4.37 |
| June 15, 2026 | 4.27 |
| June 12, 2026 | 4.33 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Replimune Group, Inc. | 14.71 |
| Arrowhead Pharmaceuticals, Inc. | 86.73 |
| Oncolytics Biotech, Inc. | 0.8441 |
| Sangamo Therapeutics, Inc. | 0.16 |
| Sarepta Therapeutics, Inc. | 18.13 |